So it allows you the leeway to put those contexts in picture when deviating to what otherwise would seem like a simple recommendation based on the guideline.

Yeah, I think then for what Ari's saying, and I wholeheartedly agree with that, that I think that often people, they want a black and white, you know, answer.

Here's what you do.

But the more we learn, especially about ARDS, we know there are different phenotypes.

And I suspect as that literature continues to come out, we'll get better at deciding which of these regimens and which patients we should use.

But right now, we don't know.

Again, what we know is that there are definitely these different subsets of patients.

But what's the best strategy to consistently obtain that across all our, uh, ARDS management strategies? That's gonna be the golden question for ARDS researchers going forward, and I hope that these guidelines trigger that curiosity and work towards that lead.